Is it legal to buy Ozempic from Canada?

In most cases, not as a personal import. FDA says that in most circumstances it is illegal for individuals to import drugs for personal use, and that a drug approved in another country but unapproved in the U.S. is illegal to import. FDA staff "may consider a more permissive decision" only in narrow cases, such as a serious condition without effective treatment at home, no more than about three months' supply and a named U.S.-licensed doctor.

Is Canada's generic semaglutide the same as Ozempic?

Health Canada says its generic semaglutide products are pharmaceutically equivalent to the brand and were reviewed against its safety, efficacy and quality criteria for generics. That is a Canadian decision. None of these products is authorized for sale in the U.S., so under FDA's personal importation policy they count as unapproved new drugs for an American buyer, whatever their quality in Canada.

Which companies make generic semaglutide in Canada?

As of September 23, 2026, the day this article was written, Health Canada's Drug Product Database listed generic semaglutide injections from Dr. Reddy's, Apotex, Aspen and Sandoz. Dr. Reddy's was first, authorized April 28, 2026; Apotex's Sevmia was the first generic for weight management, on June 29. Only the Dr. Reddy's and Apotex type 2 diabetes products were listed as marketed; the others, including Sandoz's pens, were approved but not yet on sale.

Does the new customs rule affect mailed prescriptions?

It adds paperwork rather than changing FDA's policy. Under a CBP rule published June 24, 2026, formal entry, the full customs declaration, is required from October 22 for any mail shipment subject to another government agency's requirements, and medicines come under FDA's. The rule does not mention prescriptions by name. FDA's position that personal imports of unapproved drugs are generally not permitted stays the same.

Is compounded semaglutide a generic?

No. A compounded preparation is not a generic: a generic must receive its own FDA approval by showing it matches a brand product. Compounded semaglutide is prepared by a licensed pharmacy for one patient on a prescription, which is different from an FDA-approved product, and the formulation offered through Promise is not FDA-approved. A licensed provider may still prescribe it when the clinical and legal conditions are met.

Buy Semaglutide From Canada? What Sandoz Changes

If you're hoping to buy semaglutide from Canada and have it mailed home, the new Canadian generics don't open that door. On September 18, 2026, Sandoz announced that Health Canada had authorized its generic version of Ozempic, making it the fourth company with a generic semaglutide approved there. Nothing moved on the U.S. side. FDA says a drug approved in another country but not here is illegal to import, and its staff may make exceptions only in narrow cases. The one real change is at the border: a customs rule that adds paperwork for mailed parcels from October 22.

What happened in Canada

Sandoz's release, datelined Basel, September 18, says Health Canada authorized Sandoz Semaglutide, "a generic version of Ozempic." It's approved for adults with type 2 diabetes, to improve blood-sugar control, as a once-weekly injection in two pens: one delivering 0.25 mg and 0.5 mg doses, one delivering 1 mg doses (Sandoz, September 18, 2026). A generic is a copy a regulator has checked against the brand for the same active ingredient, strength and performance.

As of September 23, 2026, the day this article was written, Health Canada's Drug Product Database listed Sandoz's pens as approved (status date September 16), among generic semaglutide injections from four companies: Dr. Reddy's, Apotex, Aspen and Sandoz. Only Dr. Reddy's injection and Apotex's diabetes version were listed as marketed, meaning actually on sale. The earlier approvals, including Dr. Reddy's in April and Apotex's weight-management version, Sevmia, in June, are covered in our generic semaglutide explainer.

Can you buy semaglutide from Canada and bring it home?

For most people, it isn't legal. FDA's personal importation page, which covers medicine brought in for your own use by suitcase or mail, says: "In most circumstances, it is illegal for individuals to import drugs or devices into the U.S. for personal use." It goes on: "If a drug is approved for use in another country but is an unapproved new drug in the U.S. it is illegal to import" (FDA, content current as of August 18, 2025). A Canadian generic is exactly that: authorized there, not here.

The page does describe exceptions: FDA staff "may consider a more permissive decision" when, among other conditions, the drug treats "a serious condition for which effective treatment may not be available domestically," nobody is promoting it to Americans, the amount is "generally not more than a three month supply," and you can name the U.S.-licensed doctor responsible for your treatment or show you started it abroad. That's a list written for treatments people can't get at home. Semaglutide is sold in U.S. pharmacies under brand names.

The one federal program for importing drugs from Canada, under section 804 of the Food, Drug, and Cosmetic Act, "allows states and Indian tribes to import certain prescription drugs from Canada" (FDA). It's for states, not shoppers.

A customs change for mailed parcels on October 22

A U.S. Customs and Border Protection rule published in the Federal Register on June 24, 2026, and effective July 24, indefinitely suspends the "de minimis" exemption, which let parcels worth $800 or less enter duty-free with little paperwork, for packages arriving by international mail (CBP, 91 FR 37801). CBP ties the change to catching health and safety violations and illicit drugs such as fentanyl.

The part with a date on it: from October 22, 2026, "formal entry is required for any mail shipment subject to the requirements of another government agency," with an optional electronic test process opening the same day. Formal entry is the full customs declaration, and medicines come under FDA's import requirements. The rule doesn't name prescriptions and doesn't change FDA's policy; it adds paperwork between a mailed package and the person waiting for it.

Why the U.S. still has no generic semaglutide

Canada's decisions don't carry over, because approvals and patents stop at the border. FDA's Orange Book, its register of approved drugs and their patents, lists the patent on the semaglutide molecule itself as expiring December 5, 2031 (FDA Orange Book).

Two other things get mistaken for it. A compounded preparation is not a generic: a generic must receive its own FDA approval by showing it matches a brand product, while compounding is a licensed pharmacy preparing medicine for one patient on a prescription. And tirzepatide, the other weekly GLP-1 shot, sold as Mounjaro and Zepbound, is a different molecule with its own trials, side effects and prescribing decision.

"Canadian" isn't a quality seal

The word Canada on a website carries weight it hasn't earned. In January 2026, Health Canada warned that it had found "various retailers in Canada selling unauthorized GLP-1 products, both in stores and online," with some websites misusing its logo (Health Canada, January 21, 2026). Its advice to Canadians: buy only from licensed pharmacies and look for the eight-digit Drug Identification Number on the label.

Online semaglutide sold without a prescription has been tested. In a 2024 study, researchers placed orders with six websites selling it that way. Only three orders arrived. The three sellers offering Ozempic pens never delivered and asked for an extra $650 to $1,200 to "clear customs," which customs agencies confirmed was fraud (Ashraf et al., JAMA Network Open 2024). The vials that did arrive were 7% to 14% pure against the 99% on their labels, and one had elevated endotoxin, a bacterial toxin that can set off fever and inflammation. The same team's wider search found 59 illegal online pharmacy sites in search results for semaglutide (Ashraf et al., Journal of Medical Internet Research 2024).

Europe's drug-safety database shows the other end: 234 reports of suspected counterfeit semaglutide between 2018 and 2025, with about 9 in 10 of the suspected reactions classed as serious and low blood sugar turning up more often than in reports on the genuine product (Zinzi et al., Frontiers in Pharmacology 2026).

The prescription route at home

The legal way to get semaglutide in the U.S. runs through two licenses: a prescriber licensed in the state where you are, and a licensed U.S. pharmacy. That can mean a brand product such as Ozempic or Wegovy through insurance, a retail pharmacy or the maker's self-pay program, which our semaglutide cost guide compares. It can also mean a compounded prescription, when a prescriber documents a patient-specific reason and the legal conditions are met.

Through Promise, semaglutide is dispensed as a compounded medication, which is different from an FDA-approved product: the formulation offered here is not FDA-approved. A licensed provider may still prescribe a compounded formulation when the clinical and legal conditions are met; that decision is between you and your doctor.

What separates this from a cross-border parcel is accountability: a named prescriber who reads your history, a licensed U.S. pharmacy on the label with a lot number it can trace, and someone to call if something feels wrong. At Promise, a licensed provider reviews every request, and not everyone qualifies. The steps are laid out in how to get semaglutide prescribed.

What to watch next

In Canada, the next step is launches. Sandoz says it "foresees no material contribution this year from any potential launches of generic semaglutide," and the database will show Sevmia, the Aspen products and Sandoz's pens move from approved to marketed when they reach pharmacy counters.

At the U.S. border, October 22 is when formal entry starts for mail covered by another agency's rules.

In the U.S., Apotex announced in April that its generic application had tentative approval, which means it can't be sold until patents and other barriers clear. The signal to wait for is a final approval in FDA's own records. Sandoz's release also notes that FDA has accepted its applications for generic tirzepatide, a filing step rather than a green light. A Canadian headline doesn't change what can be sold or shipped here.